ClinicalTrials.gov
public full text
Public Domain
AZD2171 in Treating Patients With Recurrent Glioblastoma Multiforme
This phase II trial is studying how well AZD2171 works in treating patients with recurrent glioblastoma multiforme. AZD2171 may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis#623513
- Tivozanib for Recurrent Glioblastoma#1152643
- Study of Niacin in Glioblastoma#889975
- Study of Everolimus (RAD001) in Patients With Recurrent Glioblastoma Multiforme (GBM)#1310228
- Conducting a randomized controlled clinical trial on palliative care in patients with glioblastoma - what are the challenges?#143094
Record · ID 1396393
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive